Intra Cellular Therapies shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $29M | 412k | 69.20 |
| 2023-09-30 | $3.8M | 73k | 52.09 |
| 2023-06-30 | $4.9M | 78k | 63.32 |
| 2023-03-31 | $4.4M | 81k | 54.15 |
| 2022-12-31 | $2.6M | 50k | 52.91 |
| 2022-09-30 | $343k | 7.4k | 46.52 |
| 2022-06-30 | $498k | 8.7k | 57.10 |
| 2022-03-31 | $458k | 7.5k | 61.22 |
| 2019-12-31 | $288k | 8.4k | 34.34 |
| 2019-06-30 | $149k | 12k | 12.94 |
| 2016-06-30 | $328k | 8.5k | 38.77 |
| 2016-03-31 | $231k | 8.3k | 27.80 |
| 2015-12-31 | $3.3M | 61k | 53.78 |
| 2015-09-30 | $1.7M | 43k | 40.04 |
| 2015-06-30 | $1.5M | 48k | 31.96 |
| 2014-09-30 | $0 | 5 | 0.00 |